Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bicara Therapeutics Inc. (BCAX) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bicara Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2023658.
Total stock buying since 2024: $34,254,000.
Total stock sales since 2024: $3,891,146.
Total stock option exercises since 2024: $1,125,774.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 243,657 | $3,891,146 | 220,657 | $1,125,774 |
| 2024 | 1,903,000 | $34,254,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-10 | 0 | $0 | 146,534 | $2,681,772 | 123,534 | $468,191 |
| 2025-09 | 0 | $0 | 81,294 | $1,044,278 | 81,294 | $571,315 |
| 2025-06 | 0 | $0 | 15,829 | $165,096 | 15,829 | $86,268 |
| 2024-09 | 1,903,000 | $34,254,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-10-15 | Mazumdar Claire (Chief Executive Officer) | Sale | 13,289 | 18.84 | 250,391 |
| 2025-10-15 | Mazumdar Claire (Chief Executive Officer) | Option Ex | 13,289 | 3.79 | 50,365 |
| 2025-10-15 | Cohlhepp Ryan (President and COO) | Sale | 12,500 | 18.16 | 226,937 |
| 2025-10-15 | Cohlhepp Ryan (President and COO) | Option Ex | 8,000 | 3.79 | 30,320 |
| 2025-10-13 | Mazumdar Claire (Chief Executive Officer) | Sale | 11,445 | 18.92 | 216,550 |
| 2025-10-13 | Mazumdar Claire (Chief Executive Officer) | Option Ex | 11,445 | 3.79 | 43,376 |
| 2025-10-09 | Raben David (Chief Medical Officer) | Sale | 22,000 | 18.45 | 405,900 |
| 2025-10-09 | Raben David (Chief Medical Officer) | Option Ex | 22,000 | 3.79 | 83,380 |
| 2025-10-09 | Hyep Ivan (Chief Financial Officer) | Sale | 6,415 | 18.23 | 116,932 |
| 2025-10-09 | Hyep Ivan (Chief Financial Officer) | Option Ex | 6,415 | 3.79 | 24,312 |
| 2025-10-08 | Hyep Ivan (Chief Financial Officer) | Sale | 5,627 | 18.21 | 102,456 |
| 2025-10-08 | Hyep Ivan (Chief Financial Officer) | Option Ex | 5,627 | 3.79 | 21,326 |
| 2025-10-07 | Hyep Ivan (Chief Financial Officer) | Sale | 18,244 | 18.22 | 332,387 |
| 2025-10-07 | Hyep Ivan (Chief Financial Officer) | Option Ex | 18,244 | 3.79 | 69,144 |
| 2025-10-07 | Cohlhepp Ryan (President and COO) | Sale | 10,900 | 18.06 | 196,843 |
| 2025-10-07 | Cohlhepp Ryan (President and COO) | Option Ex | 8,000 | 3.79 | 30,320 |
| 2025-10-06 | Hyep Ivan (Chief Financial Officer) | Sale | 6,514 | 18.17 | 118,359 |
| 2025-10-06 | Hyep Ivan (Chief Financial Officer) | Option Ex | 6,514 | 3.79 | 24,688 |
| 2025-10-06 | Cohlhepp Ryan (President and COO) | Sale | 39,600 | 18.06 | 715,017 |
| 2025-10-06 | Cohlhepp Ryan (President and COO) | Option Ex | 24,000 | 3.79 | 90,960 |
| 2025-09-29 | Meisner Lara (Chief Legal Officer) | Sale | 33,807 | 14.75 | 498,653 |
| 2025-09-29 | Meisner Lara (Chief Legal Officer) | Option Ex | 33,807 | 9.24 | 312,511 |
| 2025-09-15 | Meisner Lara (Chief Legal Officer) | Sale | 31,658 | 11.49 | 363,750 |
| 2025-09-15 | Meisner Lara (Chief Legal Officer) | Option Ex | 31,658 | 5.45 | 172,536 |
| 2025-06-16 | Meisner Lara (Chief Legal Officer) | Sale | 15,829 | 10.43 | 165,096 |
| 2025-06-16 | Meisner Lara (Chief Legal Officer) | Option Ex | 15,829 | 5.45 | 86,268 |
| 2024-09-17 | Deerfield Mgmt L.p. | Buy | 70,000 | 18.00 | 1,260,000 |
| 2024-09-16 | Shah Rajeev M. | Buy | 1,833,000 | 18.00 | 32,994,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BCAX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bicara Therapeutics Inc. (symbol BCAX, CIK number 2023658) see the Securities and Exchange Commission (SEC) website.